ULTRAGENYX PHARMACEUTICAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.75 USD | -1.04% |
|
-3.37% | -10.60% |
| 03/05 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
| 02/05 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Bio Therapeutic Drugs | -1.04% | -3.37% | -10.60% | -6.68% | -37.12% | 3.55B |  |  | |
- Stock Market
- Equities
- RARE Stock
- Charts Ultragenyx Pharmaceutical Inc.
- Relative Strength Chart
